Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy.

Serological screening and seroprevalence data for TORCH infections represent a key instrument to estimate immunity and vaccination levels and exposure rates to prevent and treat TORCH congenital infections. Serology allows us to identify women susceptible to primary infection. Assess the prevalence of women at risk of primary infections by TORCH pathogens in Palermo, Sicily, Italy, in the decade 2012-2022.